Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Modern biopharmaceuticals [[electronic resource] ] : recent success stories / / edited by Jorg Knablein
| Modern biopharmaceuticals [[electronic resource] ] : recent success stories / / edited by Jorg Knablein |
| Pubbl/distr/stampa | Weinheim ; ; Chichester, : Wiley-VCH, 2013 |
| Descrizione fisica | 1 online resource (778 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) | KnableinJorg |
| Soggetto topico |
Biopharmaceutics
Drugs - Testing - Research |
| ISBN |
3-527-66943-4
3-527-66941-8 1-299-44890-9 3-527-66942-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Modern Biopharmaceuticals: Recent Success Stories; Contents; Foreword by Andreas Busch; Foreword by Günter Stock; Preface; Quotes; List of Contributors; Part I: Modern Biopharmaceuticals: Research is the Best Medicine - Sanitas Summum Bonus; 1 Twenty Thousand Years of Biotech - From "Traditional" to "Modern Biotechnology"; 1.1 Biotechnology - The Science Creating Life; 1.2 The Inauguration of Biotechnology; 1.3 From "Traditional" to "Modern Biotechnology"; 1.3.1 Molecular Genetics and Enzymatic Kinetics; 1.3.2 Penicillin and Other Lifesaving Antibiotics
1.3.3 The Triumphal Procession of Vitamin C1.4 A Small Molecule from Bacteria - A Huge Importance for Mankind; 1.4.1 Plasmids: Transformation by Gene Transfer; 1.4.2 DNA: The Molecule of Life; 1.4.3 Immortalized Cells: The Source of Monoclonal Antibodies; 1.4.4 Insulin: The First Biotech Blockbuster; 1.4.5 Polymerase Chain Reaction: How to Infinitely Amplify DNA; 1.5 Biopharmaceuticals - The Mainstay of Modern Biotechnology; 1.5.1 Modern Biopharmaceuticals in Europe; 1.6 Transformation of the Pharma Industry Through Biotechnology; 1.6.1 The Market as Motivation for Transformation 1.6.2 Innovations and Where They do Come From1.6.3 Mergers and Acquisitions in the Biopharmaceutical Industry and the Impact on Innovation; 1.6.4 A Focus on the Opportunities of European Biotech Industry; 1.7 Biopharmaceutical Production - Uncorking Bottlenecks or Wasting Surplus Capacity?; 1.8 Conclusion and Outlook; References; Part II: Modern Biopharmaceutical Development Using Stem Cells, Tissues, and Whole Animals; 2 Induced Pluripotency as Substitute of Somatic Cell Nuclear Transfer? - The Impact of Induced Pluripotent Stem Cells on Drug Discovery and Regenerative Biopharmaceuticals 2.1 Introduction2.2 Derivation and Growth of hESC; 2.3 Signaling Pathways and Transcription Factors; 2.4 Differentiation and Applications of hESC; 2.5 Patient-Specific Nuclear Transfer Stem Cells; 2.6 Patient-Specific Pluripotent Cells Through Direct Reprogramming of Adult Somatic Cells; 2.7 Concluding Remarks and Outlook; References; 3 Pluripotent Stem Cell-Derived Cardiomyocytes for Industrial and Clinical Applications; 3.1 Introduction; 3.2 Pluripotent Stem Cells; 3.2.1 Embryonic Stem Cells; 3.2.2 Parthenogenetic Stem Cells; 3.2.3 Germline Pluripotent Stem Cells 3.2.4 Induced Pluripotent Stem Cells3.3 High-Yield Differentiation of Pluripotent Stem Cells into Cardiomyocytes; 3.4 Purification of Pluripotent Stem Cell-Derived Cardiomyocytes; 3.5 Cardiomyocytes at an Industrial Scale; 3.6 Utilization of Tissue Engineering Technologies to Advance Cellular Maturity; 3.7 Concluding Remarks; References; 4 Industrialization of Functional Mouse Genomics Technologies for Biopharmaceutical Drug Discovery and Development; 4.1 Introduction; 4.2 The Mouse Genetics Story; 4.3 Establishing Inducible Gene Targeting Tools; 4.4 RNAi - Talking About a Revolution? 4.5 Further Shortening the Generation Timeline for RNAi Mouse Models |
| Record Nr. | UNINA-9910139022003321 |
| Weinheim ; ; Chichester, : Wiley-VCH, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modern biopharmaceuticals [[electronic resource] ] : recent success stories / / edited by Jorg Knablein
| Modern biopharmaceuticals [[electronic resource] ] : recent success stories / / edited by Jorg Knablein |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Weinheim ; ; Chichester, : Wiley-VCH, 2013 |
| Descrizione fisica | 1 online resource (778 p.) |
| Disciplina | 615.19 |
| Altri autori (Persone) | KnableinJorg |
| Soggetto topico |
Biopharmaceutics
Drugs - Testing - Research |
| ISBN |
3-527-66943-4
3-527-66941-8 1-299-44890-9 3-527-66942-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Modern Biopharmaceuticals: Recent Success Stories; Contents; Foreword by Andreas Busch; Foreword by Günter Stock; Preface; Quotes; List of Contributors; Part I: Modern Biopharmaceuticals: Research is the Best Medicine - Sanitas Summum Bonus; 1 Twenty Thousand Years of Biotech - From "Traditional" to "Modern Biotechnology"; 1.1 Biotechnology - The Science Creating Life; 1.2 The Inauguration of Biotechnology; 1.3 From "Traditional" to "Modern Biotechnology"; 1.3.1 Molecular Genetics and Enzymatic Kinetics; 1.3.2 Penicillin and Other Lifesaving Antibiotics
1.3.3 The Triumphal Procession of Vitamin C1.4 A Small Molecule from Bacteria - A Huge Importance for Mankind; 1.4.1 Plasmids: Transformation by Gene Transfer; 1.4.2 DNA: The Molecule of Life; 1.4.3 Immortalized Cells: The Source of Monoclonal Antibodies; 1.4.4 Insulin: The First Biotech Blockbuster; 1.4.5 Polymerase Chain Reaction: How to Infinitely Amplify DNA; 1.5 Biopharmaceuticals - The Mainstay of Modern Biotechnology; 1.5.1 Modern Biopharmaceuticals in Europe; 1.6 Transformation of the Pharma Industry Through Biotechnology; 1.6.1 The Market as Motivation for Transformation 1.6.2 Innovations and Where They do Come From1.6.3 Mergers and Acquisitions in the Biopharmaceutical Industry and the Impact on Innovation; 1.6.4 A Focus on the Opportunities of European Biotech Industry; 1.7 Biopharmaceutical Production - Uncorking Bottlenecks or Wasting Surplus Capacity?; 1.8 Conclusion and Outlook; References; Part II: Modern Biopharmaceutical Development Using Stem Cells, Tissues, and Whole Animals; 2 Induced Pluripotency as Substitute of Somatic Cell Nuclear Transfer? - The Impact of Induced Pluripotent Stem Cells on Drug Discovery and Regenerative Biopharmaceuticals 2.1 Introduction2.2 Derivation and Growth of hESC; 2.3 Signaling Pathways and Transcription Factors; 2.4 Differentiation and Applications of hESC; 2.5 Patient-Specific Nuclear Transfer Stem Cells; 2.6 Patient-Specific Pluripotent Cells Through Direct Reprogramming of Adult Somatic Cells; 2.7 Concluding Remarks and Outlook; References; 3 Pluripotent Stem Cell-Derived Cardiomyocytes for Industrial and Clinical Applications; 3.1 Introduction; 3.2 Pluripotent Stem Cells; 3.2.1 Embryonic Stem Cells; 3.2.2 Parthenogenetic Stem Cells; 3.2.3 Germline Pluripotent Stem Cells 3.2.4 Induced Pluripotent Stem Cells3.3 High-Yield Differentiation of Pluripotent Stem Cells into Cardiomyocytes; 3.4 Purification of Pluripotent Stem Cell-Derived Cardiomyocytes; 3.5 Cardiomyocytes at an Industrial Scale; 3.6 Utilization of Tissue Engineering Technologies to Advance Cellular Maturity; 3.7 Concluding Remarks; References; 4 Industrialization of Functional Mouse Genomics Technologies for Biopharmaceutical Drug Discovery and Development; 4.1 Introduction; 4.2 The Mouse Genetics Story; 4.3 Establishing Inducible Gene Targeting Tools; 4.4 RNAi - Talking About a Revolution? 4.5 Further Shortening the Generation Timeline for RNAi Mouse Models |
| Record Nr. | UNINA-9910809372803321 |
| Weinheim ; ; Chichester, : Wiley-VCH, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nonclinical development of novel biologics, biosimilars, vaccines and specialty biologics / / edited by Lisa M. Plitnick, MS, PhD, and Danuta J. Herzyk, PhD, Merck Research Laboratories, Merck & Co., Inc. West Point, PA, USA
| Nonclinical development of novel biologics, biosimilars, vaccines and specialty biologics / / edited by Lisa M. Plitnick, MS, PhD, and Danuta J. Herzyk, PhD, Merck Research Laboratories, Merck & Co., Inc. West Point, PA, USA |
| Pubbl/distr/stampa | London, : Academic Press, 2013 |
| Descrizione fisica | 1 online resource (xv, 416 pages, 8 unnumbered pages of plates) : illustrations (some color) |
| Disciplina | 615/.19 |
| Collana | Gale eBooks |
| Soggetto topico |
Biopharmaceutics
Biologicals Biological products |
| ISBN | 0-12-394823-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics; Copyright; Dedication; Contents; Preface; Contributors; Acknowledgments; Section I Development of Biopharmaceuticals Defined as Novel Biologics; Chapter 1 - Overview of Biopharmaceuticals and Comparison with Small-molecule Drug Development; INTRODUCTION; HISTORY AND EVOLUTION OF BIOPHARMACEUTICALS; DEVELOPMENT OF DIVERSE BIOPHARMACEUTICAL MODALITIES; COMPARISON OF SMALL-MOLECULE DRUGS TO BIOPHARMACEUTICALS; SUMMARY; References
Chapter 2 - Regulatory Guidelines and their Application in the Nonclinical Evaluation of Biological MedicinesINTRODUCTION; SPECIES SELECTION; STUDY DESIGN CONSIDERATIONS FOR REPEAT-DOSE STUDIES; IMMUNOGENICITY; REPRODUCTIVE AND DEVELOPMENTAL TOXICITY; GENOTOXICITY AND CARCINOGENICITY; SPECIAL CONSIDERATIONS FOR ANTICANCER DRUGS; FIRST-IN-HUMAN (FIH) CLINICAL TRIAL; SUMMARY; References; Chapter 3 - Early De-risking Strategy for Novel Biotherapeutics; INTRODUCTION; ESTABLISHING A SAFETY PROFILE FOR BIOTHERAPEUTICS; GENERAL SAFETY CONSIDERATIONS RELATED TO BIOTHERAPEUTICS PROGRESS IN EVALUATION OF IMMUNOTOXICITYCAN WE BETTER ADDRESS POTENTIAL OFF-TARGET TOXICITY?; SUMMARY; References; Chapter 4 - Novel Biopharmaceuticals: Pharmacokinetics, Pharmacodynamics, and Bioanalytics; INTRODUCTION; ABSORPTION, DISTRIBUTION AND ELIMINATION OF BIOPHARMACEUTICALS; DISPOSITION OF MODIFIED MOLECULES; "METABOLISM" AND BIODISTRIBUTION FOR BIOPHARMACEUTICALS; IMMUNOGENICITY AND IMPACTS ON PK AND BIODISTRIBUTION; PHARMACOKINETICS AND PHARMACODYNAMICS; PRECLINICAL TO CLINICAL TRANSLATION; BIOANALYTICS; DRUG ASSAYS; BIOMARKERS: TARGET ENGAGEMENT ASSAYS IMMUNOGENICITY ASSESSMENT: ADA ASSAYSSUMMARY; References; Section II Development of Biosimilars; Chapter 5 - Overview of Biosimilar Therapeutics; INTRODUCTION; THE CONCEPT OF BIOSIMILARS; GENERAL CONSIDERATIONS FOR DEVELOPMENT OF BIOSIMILARS; BIOSIMILAR CANDIDATES BASED ON MODALITY AND THERAPEUTIC CLASS; SUMMARY; References; Chapter 6 - Regulatory Standards for the Approval of Biosimilar Products: A Global Review; INTRODUCTION; EUROPEAN UNION-PIONEER FOR THE FIRST REGULATORY PATHWAY FOR BIOSIMILAR PRODUCTS; THE WORLD HEALTH ORGANIZATION GUIDANCE ON BIOSIMILARS REGULATORY PATHWAY FOR BIOSIMILAR PRODUCTS IN THE UNITED STATESBIOSIMILAR PATHWAYS IN OTHER REGIONS; SUMMARY; References; Chapter 7 - Early Characterization of Biosimilar Therapeutics; INTRODUCTION; RECOMBINANT INSULINS; RECOMBINANT HUMAN GROWTH HORMONE; RECOMBINANT ERYTHROPOIETINS; RECOMBINANT GRANULOCYTE COLONY-STIMULATING FACTOR; RECOMBINANT INTERFERONS; LOW MOLECULAR WEIGHT HEPARINS; MONOCLONAL ANTIBODIES; OTHER CLASSES; SUMMARY; References; Section III Vaccines; Chapter 8 - Introduction to Vaccines and Adjuvants; INTRODUCTION; THE HISTORY OF VACCINES THE IMPACT OF VACCINES ON HUMAN HEALTH |
| Record Nr. | UNINA-9910779753803321 |
| London, : Academic Press, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nonclinical development of novel biologics, biosimilars, vaccines and specialty biologics / / edited by Lisa M. Plitnick, MS, PhD, and Danuta J. Herzyk, PhD, Merck Research Laboratories, Merck & Co., Inc. West Point, PA, USA
| Nonclinical development of novel biologics, biosimilars, vaccines and specialty biologics / / edited by Lisa M. Plitnick, MS, PhD, and Danuta J. Herzyk, PhD, Merck Research Laboratories, Merck & Co., Inc. West Point, PA, USA |
| Pubbl/distr/stampa | London, : Academic Press, 2013 |
| Descrizione fisica | 1 online resource (xv, 416 pages, 8 unnumbered pages of plates) : illustrations (some color) |
| Disciplina | 615/.19 |
| Collana | Gale eBooks |
| Soggetto topico |
Biopharmaceutics
Biologicals Biological products |
| ISBN | 0-12-394823-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics; Copyright; Dedication; Contents; Preface; Contributors; Acknowledgments; Section I Development of Biopharmaceuticals Defined as Novel Biologics; Chapter 1 - Overview of Biopharmaceuticals and Comparison with Small-molecule Drug Development; INTRODUCTION; HISTORY AND EVOLUTION OF BIOPHARMACEUTICALS; DEVELOPMENT OF DIVERSE BIOPHARMACEUTICAL MODALITIES; COMPARISON OF SMALL-MOLECULE DRUGS TO BIOPHARMACEUTICALS; SUMMARY; References
Chapter 2 - Regulatory Guidelines and their Application in the Nonclinical Evaluation of Biological MedicinesINTRODUCTION; SPECIES SELECTION; STUDY DESIGN CONSIDERATIONS FOR REPEAT-DOSE STUDIES; IMMUNOGENICITY; REPRODUCTIVE AND DEVELOPMENTAL TOXICITY; GENOTOXICITY AND CARCINOGENICITY; SPECIAL CONSIDERATIONS FOR ANTICANCER DRUGS; FIRST-IN-HUMAN (FIH) CLINICAL TRIAL; SUMMARY; References; Chapter 3 - Early De-risking Strategy for Novel Biotherapeutics; INTRODUCTION; ESTABLISHING A SAFETY PROFILE FOR BIOTHERAPEUTICS; GENERAL SAFETY CONSIDERATIONS RELATED TO BIOTHERAPEUTICS PROGRESS IN EVALUATION OF IMMUNOTOXICITYCAN WE BETTER ADDRESS POTENTIAL OFF-TARGET TOXICITY?; SUMMARY; References; Chapter 4 - Novel Biopharmaceuticals: Pharmacokinetics, Pharmacodynamics, and Bioanalytics; INTRODUCTION; ABSORPTION, DISTRIBUTION AND ELIMINATION OF BIOPHARMACEUTICALS; DISPOSITION OF MODIFIED MOLECULES; "METABOLISM" AND BIODISTRIBUTION FOR BIOPHARMACEUTICALS; IMMUNOGENICITY AND IMPACTS ON PK AND BIODISTRIBUTION; PHARMACOKINETICS AND PHARMACODYNAMICS; PRECLINICAL TO CLINICAL TRANSLATION; BIOANALYTICS; DRUG ASSAYS; BIOMARKERS: TARGET ENGAGEMENT ASSAYS IMMUNOGENICITY ASSESSMENT: ADA ASSAYSSUMMARY; References; Section II Development of Biosimilars; Chapter 5 - Overview of Biosimilar Therapeutics; INTRODUCTION; THE CONCEPT OF BIOSIMILARS; GENERAL CONSIDERATIONS FOR DEVELOPMENT OF BIOSIMILARS; BIOSIMILAR CANDIDATES BASED ON MODALITY AND THERAPEUTIC CLASS; SUMMARY; References; Chapter 6 - Regulatory Standards for the Approval of Biosimilar Products: A Global Review; INTRODUCTION; EUROPEAN UNION-PIONEER FOR THE FIRST REGULATORY PATHWAY FOR BIOSIMILAR PRODUCTS; THE WORLD HEALTH ORGANIZATION GUIDANCE ON BIOSIMILARS REGULATORY PATHWAY FOR BIOSIMILAR PRODUCTS IN THE UNITED STATESBIOSIMILAR PATHWAYS IN OTHER REGIONS; SUMMARY; References; Chapter 7 - Early Characterization of Biosimilar Therapeutics; INTRODUCTION; RECOMBINANT INSULINS; RECOMBINANT HUMAN GROWTH HORMONE; RECOMBINANT ERYTHROPOIETINS; RECOMBINANT GRANULOCYTE COLONY-STIMULATING FACTOR; RECOMBINANT INTERFERONS; LOW MOLECULAR WEIGHT HEPARINS; MONOCLONAL ANTIBODIES; OTHER CLASSES; SUMMARY; References; Section III Vaccines; Chapter 8 - Introduction to Vaccines and Adjuvants; INTRODUCTION; THE HISTORY OF VACCINES THE IMPACT OF VACCINES ON HUMAN HEALTH |
| Record Nr. | UNINA-9910815087903321 |
| London, : Academic Press, 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
O meu herbário de plantas medicinais
| O meu herbário de plantas medicinais |
| Autore | Fernanda Botelho |
| Pubbl/distr/stampa | Coimbra University Press, 2017 |
| Descrizione fisica | 1 electronic resource (56 p.) |
| Disciplina | 615.7 |
| Collana | Natura Naturata |
| Soggetto topico | Biopharmaceutics |
| ISBN | 989-26-1310-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | por |
| Record Nr. | UNINA-9910404230103321 |
Fernanda Botelho
|
||
| Coimbra University Press, 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The open medicinal chemistry journal
| The open medicinal chemistry journal |
| Pubbl/distr/stampa | [Hilversum], : [Bentham Science Publishers], [2007]-[2008] |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Biochemistry
Clinical chemistry Pharmaceutical chemistry Biochemical Phenomena Chemistry, Clinical Biopharmaceutics |
| Soggetto genere / forma |
Periodicals.
Fulltext Internet Resources. Periodical |
| Soggetto non controllato | Biochemistry |
| ISSN | 1874-1045 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | TOMCJ |
| Record Nr. | UNISA-996209655303316 |
| [Hilversum], : [Bentham Science Publishers], [2007]-[2008] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
The open medicinal chemistry journal
| The open medicinal chemistry journal |
| Pubbl/distr/stampa | [Hilversum], : [Bentham Science Publishers], [2007]-[2008] |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Biochemistry
Clinical chemistry Pharmaceutical chemistry Biochemical Phenomena Chemistry, Clinical Biopharmaceutics |
| Soggetto genere / forma |
Periodicals.
Fulltext Internet Resources. Periodical |
| Soggetto non controllato | Biochemistry |
| ISSN | 1874-1045 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | TOMCJ |
| Record Nr. | UNINA-9910144042203321 |
| [Hilversum], : [Bentham Science Publishers], [2007]-[2008] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
PAT applied in biopharmaceutical process development and manufacturing : an enabling tool for quality-by-design / / edited by Cenk Undey. [et al.]
| PAT applied in biopharmaceutical process development and manufacturing : an enabling tool for quality-by-design / / edited by Cenk Undey. [et al.] |
| Pubbl/distr/stampa | Boca Raton, Fla. : , : CRC Press, , 2012 |
| Descrizione fisica | 1 online resource (320 p.) |
| Disciplina | 615.1/9 |
| Altri autori (Persone) | UndeyCenk |
| Collana | Biotechnology and bioprocessing series |
| Soggetto topico |
Pharmaceutical biotechnology
Biopharmaceutics Drug development |
| Soggetto genere / forma | Electronic books. |
| ISBN |
0-429-15172-1
1-280-12184-X 9786613525703 1-4398-2946-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Dedication; Contents; Foreword; Introduction; Contributors; Chapter 1: Scientific and Regulatory Overview of Process Analytical Technology in Bioprocesses; Chapter 2: Strategic Vision for Integrated Process Analytical Technology and Advanced Control in Biologics Manufacturing; Chapter 3: Multivariate Techniques in Biopharmaceutical Process Development; Chapter 4: Analysis, Monitoring, Control, and Optimization of Batch Processes: Multivariate Dynamic Data Modeling; Chapter 5: Multivariate Data Analysis in Biopharmaceuticals
Chapter 6: Process Analytical Technology Advances and Applications in Recombinant Protein Cell Culture ProcessesChapter 7: Process Analytical Technology Applied to Raw Materials; Chapter 8: Process Analysis Technology for Enhanced Verification of Bioprocess System Cleaning; Chapter 9: Cell Culture Process Analytical Technology Multiplexing Near-Infrared; Chapter 10: Process Analytical Technology for Bioseparation Unit Operations; Chapter 11: Process Analytical Technology Use in Biofuels Manufacturing Chapter 12: Application of Microreactors for Innovative Bioprocess Development and ManufacturingChapter 13: Real-Time Monitoring and Controlling of Lyophilization Process Parameters through Process Analytical Technology Tools; Chapter 14: Process Analytical Technology's Role in Operational Excellence; Chapter 15: Conclusions, Current Status, and Future Vision of Process Analytical Technology in Biologics |
| Record Nr. | UNINA-9910457189703321 |
| Boca Raton, Fla. : , : CRC Press, , 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
PAT applied in biopharmaceutical process development and manufacturing : an enabling tool for quality-by-design / / edited by Cenk Undey. [et al.]
| PAT applied in biopharmaceutical process development and manufacturing : an enabling tool for quality-by-design / / edited by Cenk Undey. [et al.] |
| Pubbl/distr/stampa | Boca Raton, Fla. : , : CRC Press, , 2012 |
| Descrizione fisica | 1 online resource (320 p.) |
| Disciplina | 615.1/9 |
| Altri autori (Persone) | UndeyCenk |
| Collana | Biotechnology and bioprocessing series |
| Soggetto topico |
Pharmaceutical biotechnology
Biopharmaceutics Drug development |
| ISBN |
0-429-15172-1
1-280-12184-X 9786613525703 1-4398-2946-2 |
| Classificazione | MED071000SCI010000SCI013010 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Dedication; Contents; Foreword; Introduction; Contributors; Chapter 1: Scientific and Regulatory Overview of Process Analytical Technology in Bioprocesses; Chapter 2: Strategic Vision for Integrated Process Analytical Technology and Advanced Control in Biologics Manufacturing; Chapter 3: Multivariate Techniques in Biopharmaceutical Process Development; Chapter 4: Analysis, Monitoring, Control, and Optimization of Batch Processes: Multivariate Dynamic Data Modeling; Chapter 5: Multivariate Data Analysis in Biopharmaceuticals
Chapter 6: Process Analytical Technology Advances and Applications in Recombinant Protein Cell Culture ProcessesChapter 7: Process Analytical Technology Applied to Raw Materials; Chapter 8: Process Analysis Technology for Enhanced Verification of Bioprocess System Cleaning; Chapter 9: Cell Culture Process Analytical Technology Multiplexing Near-Infrared; Chapter 10: Process Analytical Technology for Bioseparation Unit Operations; Chapter 11: Process Analytical Technology Use in Biofuels Manufacturing Chapter 12: Application of Microreactors for Innovative Bioprocess Development and ManufacturingChapter 13: Real-Time Monitoring and Controlling of Lyophilization Process Parameters through Process Analytical Technology Tools; Chapter 14: Process Analytical Technology's Role in Operational Excellence; Chapter 15: Conclusions, Current Status, and Future Vision of Process Analytical Technology in Biologics |
| Record Nr. | UNINA-9910778822703321 |
| Boca Raton, Fla. : , : CRC Press, , 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
PAT applied in biopharmaceutical process development and manufacturing : an enabling tool for quality-by-design / / edited by Cenk Undey. [et al.]
| PAT applied in biopharmaceutical process development and manufacturing : an enabling tool for quality-by-design / / edited by Cenk Undey. [et al.] |
| Pubbl/distr/stampa | Boca Raton, Fla. : , : CRC Press, , 2012 |
| Descrizione fisica | 1 online resource (320 p.) |
| Disciplina | 615.1/9 |
| Altri autori (Persone) | UndeyCenk |
| Collana | Biotechnology and bioprocessing series |
| Soggetto topico |
Pharmaceutical biotechnology
Biopharmaceutics Drug development |
| ISBN |
0-429-15172-1
1-280-12184-X 9786613525703 1-4398-2946-2 |
| Classificazione | MED071000SCI010000SCI013010 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Dedication; Contents; Foreword; Introduction; Contributors; Chapter 1: Scientific and Regulatory Overview of Process Analytical Technology in Bioprocesses; Chapter 2: Strategic Vision for Integrated Process Analytical Technology and Advanced Control in Biologics Manufacturing; Chapter 3: Multivariate Techniques in Biopharmaceutical Process Development; Chapter 4: Analysis, Monitoring, Control, and Optimization of Batch Processes: Multivariate Dynamic Data Modeling; Chapter 5: Multivariate Data Analysis in Biopharmaceuticals
Chapter 6: Process Analytical Technology Advances and Applications in Recombinant Protein Cell Culture ProcessesChapter 7: Process Analytical Technology Applied to Raw Materials; Chapter 8: Process Analysis Technology for Enhanced Verification of Bioprocess System Cleaning; Chapter 9: Cell Culture Process Analytical Technology Multiplexing Near-Infrared; Chapter 10: Process Analytical Technology for Bioseparation Unit Operations; Chapter 11: Process Analytical Technology Use in Biofuels Manufacturing Chapter 12: Application of Microreactors for Innovative Bioprocess Development and ManufacturingChapter 13: Real-Time Monitoring and Controlling of Lyophilization Process Parameters through Process Analytical Technology Tools; Chapter 14: Process Analytical Technology's Role in Operational Excellence; Chapter 15: Conclusions, Current Status, and Future Vision of Process Analytical Technology in Biologics |
| Record Nr. | UNINA-9910820942703321 |
| Boca Raton, Fla. : , : CRC Press, , 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Biopharmaceutics
(106)
- Pharmacology (21)
- Pharmaceutical chemistry (19)
- Drugs - Design (16)
- Drug development (14)